The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

Schoonheim, MM; Ciccarelli, O; (2018) The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis. Neurology (In press).

http://ift.tt/2Csc8SC